Multigene panel testing for hereditary breast and ovarian cancers: An analysis of 1303 BRCA-negative Chinese patients. This is an ASCO Meeting Abstract from the 2018 ASCO Annual Meeting I. This ...
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. AstraZeneca is currently conducting a ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果